SCHEMBL21993055

SCHEMBL21993055

N#CC1=C(N)Oc2c(c(=O)oc3ccc(F)cc23)C1c1ccc(-c2ccc(C(F)(F)F)nc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.52
KDM4E B2RXH2 10/20 0.51
KMT2A Q03164 9/20 0.51
TSHR P16473 3/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
TOP2A P11388 4/20 0.51
MEN1 O00255 7/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
ALDH1A1 P00352 6/20 0.47
GAA P10253 2/20 0.43
HTT P42858 2/20 0.43
POLB P06746 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
CASP6 P55212 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
XDH P47989 1/20 0.42
HPGD P15428 2/20 0.42
GLA P06280 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21993292 0.88 MAPT (0.53) MAPTKDM4EKMT2ATSHRSMN1; SMN2
SCHEMBL21993405 0.86 KDM4E (0.54) MAPTKDM4EKMT2ATSHRSMN1; SMN2
SCHEMBL21993029 0.86 MAPT (0.57) MAPTKDM4EKMT2ATSHRSMN1; SMN2
SCHEMBL21993437 0.86 MAPT (0.67) MAPTKDM4EKMT2ATSHRSMN1; SMN2
SCHEMBL21992931 0.85 KMT2A (0.64) MAPTKDM4EKMT2ATSHRSMN1; SMN2
SCHEMBL21993030 0.85 MAPT (0.55) MAPTKDM4EKMT2ATSHRSMN1; SMN2
SCHEMBL21992933 0.83 KDM4E (0.50) MAPTKDM4EKMT2ATSHRSMN1; SMN2
SCHEMBL21993446 0.81 MAPT (0.58) MAPTKDM4EKMT2ATSHRSMN1; SMN2
SCHEMBL21993050 0.80 MAPT (0.52) MAPTKDM4EKMT2ATSHRSMN1; SMN2
SCHEMBL21993008 0.79 MAPT (0.55) MAPTKDM4EKMT2ATSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11141402-B2 Compounds useful in inhibiting human trefoil factor 3 NATIONAL UNIVERSITY OF SINGAPORE (SG) 2021-10-12 US disclosed
US-20200147039-A1 COMPOUNDS USEFUL IN INHIBITING HUMAN TREFOIL FACTOR 3 NATIONAL UNIVERSITY OF SINGAPORE (SG) 2020-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11141402-B2 Compounds useful in inhibiting human trefoil factor 3 ETF1, F3, DNASE1L3 MAPT 4590/4885KDM4E 3966/4885KMT2A 4155/4885
US-20200147039-A1 COMPOUNDS USEFUL IN INHIBITING HUMAN TREFOIL FACTOR 3 ETF1, F3, DNASE1L3 MAPT 4590/4885KDM4E 3966/4885KMT2A 4155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.